8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Feb 5, 2008)

Filed February 5, 2008For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) filed a Form 8-K on February 5, 2008, to report its financial results for the fourth quarter and full year ended December 31, 2007. The filing primarily consists of a press release that details the company's performance. Investors should note that while most of the press release content is furnished and not deemed "filed" under the Exchange Act, specific sections concerning the "Twelve-Month Results" and the initial two paragraphs of the press release are considered filed, making them subject to specific disclosure requirements. The key takeaway for investors is the announcement of the company's financial performance for the period. While the 8-K itself doesn't contain detailed financial tables, it serves as the official notification of the release of these results, which would have been disseminated via the attached press release (Exhibit 99.1). Investors would need to refer to the press release for the actual figures, including revenue, earnings, and any forward-looking guidance provided.

Key Highlights

  • 1Edwards Lifesciences (EW) filed an 8-K on February 5, 2008, to announce its Q4 and Full Year 2007 financial results.
  • 2The filing's primary content is a press release (Exhibit 99.1) detailing the financial outcomes for the period.
  • 3Specific portions of the press release, including the first two paragraphs and the 'Twelve-Month Results' section, are deemed "filed" under the Securities Exchange Act of 1934.
  • 4The majority of the press release content is furnished, meaning it's not formally "filed" with the SEC.
  • 5The 8-K serves as official notification of the earnings release date.
  • 6Investors are directed to the attached press release (Exhibit 99.1) for specific financial figures and commentary.

Frequently Asked Questions

The main purpose of this Form 8-K filing is to officially announce and report Edwards Lifesciences Corporation's financial results for the fourth quarter and the full fiscal year 2007.

The detailed financial results are contained within the press release attached as Exhibit 99.1 to this 8-K filing. Investors should refer to this press release for specific revenue, earnings, and other financial data.

Information 'furnished' under Item 2.02 generally does not carry the same legal liability as 'filed' information. However, specific paragraphs of the press release in this filing are designated as 'filed,' meaning they are subject to the reporting requirements and liabilities under the Securities Exchange Act of 1934.

This 8-K filing itself does not provide forward-looking guidance. Such information would typically be found within the accompanying press release (Exhibit 99.1), which investors should consult for any future outlook or projections provided by the company.